Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARISMA THERAPEUTICS INC - Price to Operating Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CARM - P/OCF Historical data
| Date | Market Capitalization | Net Cash Flow - Operations | Price to Operating Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 11.49M | $ -37.34M | 0 |
| 3/31/2025 | $ 7.77M | $ -47.56M | 0 |
| 12/31/2024 | $ 12.95M | $ -59.92M | 0 |
| 9/30/2024 | $ 43M | $ -67.66M | 0 |
| 6/30/2024 | $ 37.43M | $ -75.64M | 0 |
| 3/31/2024 | $ 62.73M | $ -78.07M | 0 |
| 12/31/2023 | $ 86.82M | $ -81.18M | 0 |
| 9/30/2023 | $ 106.74M | $ -62.4M | 0 |
| 6/30/2023 | $ 238.89M | $ -17.75M | 0 |
| 3/31/2023 | $ 227.44M | $ -7.79M | 0 |
Key Performance Insights, Last 5 Years
- CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) P/OCF stands at 0.
- Over the past 5 years, CARISMA THERAPEUTICS INC's average P/OCF has been 8.12.
- The median P/OCF for CARISMA THERAPEUTICS INC during this period was 8.12
- CARISMA THERAPEUTICS INC reached its highest P/OCF over the past 5 years at 11.49.
- The lowest P/OCF recorded by CARISMA THERAPEUTICS INC in the same timeframe 4.74
Similar metrics to P/OCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Price to Operating Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].Market Cap / CF - Operations
(=) P/OCF P/OCF for CARISMA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 143.57M ] / CF - Operations [ $ -36.13M ]
(=) P/OCF [ 0 ] CARM - Price to Operating Cash Flow, Last 5 years
4.74
Minimum
Dec 31, 2022
11.49
Maximum
Sep 30, 2022
8.12
Average
8.12
Median
P/OCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/OCF for companies in the Total Stock Market. The average P/OCF of the companies is 13.09 with a standard deviation of 8.8.
The following table provides additional summary stats:
P/OCF in the Market:
| filtered constituents | 2.56K |
|---|---|
| min | 0.08 |
| max | 42.03 |
| average | 13.09 |
| median | 10.76 |
| std | 8.8 |